Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Different properties of antibodies to citrullinated proteins/peptides and IgM rheumatoid factor derived from a large dataset: Further evidence of two distinct autoantibody systems
Arthritis Research & Therapy, 05/26/09
Ursum J et al. – Study reports that antibodies to citrullinated proteins/peptides (ACPA) status is more stable in time and with increasing age than IgM-rheumtoid factor (IgM-RF) status, further establishing its role as a disease specific marker. ACPA and IgM-RF levels are only moderately correlated with markers of inflammation.
Methods- Aim was to examine seroconversion and the relationship with age and inflammation of autoantibodies
- ACPA and IgM-RF levels were determined in 22,427 samples collected from 18,658 pts
- Diagnosis was derived from the diagnosis registration system
- Degree of seroconversion in repeated samples and the correlation of levels with age and inflammatory markers was determined for ACPA and IgM-RF in RA and non-RA pts
- 71% of RA pts were ACPA positive and 53% IgM-RF positivevs 2% and 4%, respectively in non-RA pts
- In pts with at least 2 samples, ACPA status was more stable than IgM-RF status in RA pts
- ACPA or IgM-RF negative non-RA pts seldom became positive
- ACPA positivity was unrelated to age both in RA and non-RA
- IgM-RF positivity was unrelated to age in RA, however, it increased with age in non-RA pts
- Correlation between autoantibody levels and inflammatory markers was low in general, and somewhat higher for IgM-RF than for ACPA
Related Articles
Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis
Arthritis Research & Therapy, 10/07/09
Relevance Score: 78%
Lung involvement in patients with primary Sjögrens syndrome: What are the predictors?
Rheumatology International, 10/26/09
Relevance Score: 77%
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Rheumatology International, 10/30/09
Relevance Score: 68%
Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09
Relevance Score: 67%
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
Arthritis Research & Therapy, 10/20/09
Relevance Score: 67%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Depletion of functionally active CD20+ T cells by rituximab treatment
Arthritis & Rheumatism, 12/07/09
Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions
International Journal of Clinical Rheumatology, 12/04/09
Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension
Journal of Rheumatology, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


